BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37307629)

  • 41. Study of paediatric patients with the clinical and biochemical phenotype of glucose transporter type 1 deficiency syndrome.
    Jiménez Legido M; Cortés Ledesma C; Bernardino Cuesta B; López Marín L; Cantarín Extremera V; Pérez-Cerdá C; Pérez González B; López Martín E; González Gutiérrez-Solana L
    Neurologia (Engl Ed); 2022 Mar; 37(2):91-100. PubMed ID: 35279228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crystal structure of the human glucose transporter GLUT1.
    Deng D; Xu C; Sun P; Wu J; Yan C; Hu M; Yan N
    Nature; 2014 Jun; 510(7503):121-5. PubMed ID: 24847886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Towards a more palatable treatment for Glut1 deficiency syndrome.
    Brockmann K
    Dev Med Child Neurol; 2011 Jul; 53(7):580-1. PubMed ID: 21585366
    [No Abstract]   [Full Text] [Related]  

  • 44. Mutational and functional analysis of Glucose transporter I deficiency syndrome.
    Nakamura S; Osaka H; Muramatsu S; Aoki S; Jimbo EF; Yamagata T
    Mol Genet Metab; 2015 Nov; 116(3):157-62. PubMed ID: 26304067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenotypic and Genotypic Spectrum of Glucose Transporter-1 Deficiency Syndrome.
    Bourque DK; Cordeiro D; Nimmo GAM; Kobayashi J; Mercimek-Andrews S
    Can J Neurol Sci; 2021 Nov; 48(6):826-830. PubMed ID: 33431108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanotechnology may provide hope for patients with glucose transporter type 1 deficiency syndrome.
    Asadi-Pooya AA; Mirzaei E
    Epileptic Disord; 2022 Jun; 24(3):630-632. PubMed ID: 35653086
    [No Abstract]   [Full Text] [Related]  

  • 47. Glut1 deficiency syndrome: Absence epilepsy and La Soupe du Jour.
    Thouin A; Crompton DE
    Pract Neurol; 2016 Feb; 16(1):50-2. PubMed ID: 26336901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erythroid glucose transport in health and disease.
    Guizouarn H; Allegrini B
    Pflugers Arch; 2020 Sep; 472(9):1371-1383. PubMed ID: 32474749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Criss-cross gait: A clue to glucose transporter type 1 deficiency syndrome.
    Magrinelli F; Mulroy E; Schneider SA; Latorre A; Di Lazzaro G; Hennig A; Grünewald S; De Vivo DC; Bhatia KP
    Neurology; 2020 Sep; 95(11):500-501. PubMed ID: 32753446
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical presentation, EEG studies, and novel mutations in two cases of GLUT1 deficiency syndrome in Japan.
    Ito Y; Gertsen E; Oguni H; Nakayama T; Matsuo M; Funatsuka M; Voit T; Klepper J; Osawa M
    Brain Dev; 2005 Jun; 27(4):311-7. PubMed ID: 15862198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Favourable response to ketogenic dietary therapies: undiagnosed glucose 1 transporter deficiency syndrome is only one factor.
    Schoeler NE; Cross JH; Drury S; Lench N; McMahon JM; MacKay MT; Scheffer IE; Sander JW; Sisodiya SM
    Dev Med Child Neurol; 2015 Oct; 57(10):969-76. PubMed ID: 25914049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 23 years follow-up study identifies GLUT1 deficiency syndrome initially diagnosed as complicated hereditary spastic paraplegia.
    Diomedi M; Gan-Or Z; Placidi F; Dion PA; Szuto A; Bengala M; Rouleau GA; Gigli GL
    Eur J Med Genet; 2016 Nov; 59(11):564-568. PubMed ID: 27725288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new mouse model of GLUT1 deficiency syndrome exhibits abnormal sleep-wake patterns and alterations of glucose kinetics in the brain.
    Furuse T; Mizuma H; Hirose Y; Kushida T; Yamada I; Miura I; Masuya H; Funato H; Yanagisawa M; Onoe H; Wakana S
    Dis Model Mech; 2019 Sep; 12(9):. PubMed ID: 31399478
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical and biochemical hallmarks generally associated with GLUT1DS may be caused by defects in genes other than SLC2A1.
    Sánchez-Lijarcio O; Yubero D; Leal F; Couce ML; González Gutiérrez-Solana L; López-Laso E; García-Cazorla À; Pías-Peleteiro L; de Azua Brea B; Ibáñez-Micó S; Mateo-Martínez G; Troncoso-Schifferli M; Witting-Enriquez S; Ugarte M; Artuch R; Pérez B
    Clin Genet; 2022 Jul; 102(1):40-55. PubMed ID: 35388452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sleep Disorder: An Overlooked Manifestation of Glucose Transporter Type-1 Deficiency Syndrome.
    Anurat K; Khongkhatithum C; Tim-Aroon T; Limwongse C; Thampratankul L
    Neuropediatrics; 2022 Apr; 53(2):129-132. PubMed ID: 34674205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Refractory absence epilepsy associated with GLUT-1 deficiency syndrome.
    Byrne S; Kearns J; Carolan R; Mc Menamin J; Klepper J; Webb D
    Epilepsia; 2011 May; 52(5):1021-4. PubMed ID: 21366555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overlap of autism spectrum disorder and glucose transporter 1 deficiency syndrome associated with a heterozygous deletion at the 1p34.2 region.
    Lee MS; Kim YJ; Kim EJ; Lee MJ
    J Neurol Sci; 2015 Sep; 356(1-2):212-4. PubMed ID: 26117362
    [No Abstract]   [Full Text] [Related]  

  • 58. Glucose transporter 1 deficiency syndrome: nutritional and growth pattern phenotypes at diagnosis.
    Bertoli S; Masnada S; De Amicis R; Sangiorgio A; Leone A; Gambino M; Lessa C; Tagliabue A; Ferraris C; De Giorgis V; Battezzati A; Zuccotti GV; Veggiotti P; Mameli C
    Eur J Clin Nutr; 2020 Sep; 74(9):1290-1298. PubMed ID: 32404902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intermittent Ataxia with Early Onset Absence Epilepsy in Glucose Transporter Type 1 Deficiency Syndrome.
    Gowda VK; Sheshu S
    Indian Pediatr; 2015 Nov; 52(11):997. PubMed ID: 26615362
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of non-coding variation in GLUT1 deficiency.
    Liu YC; Lee JW; Bellows ST; Damiano JA; Mullen SA; Berkovic SF; Bahlo M; Scheffer IE; Hildebrand MS;
    Dev Med Child Neurol; 2016 Dec; 58(12):1295-1302. PubMed ID: 27265003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.